Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILE maintenance strategy trial in children with HIV
ISRCTN11193709Phase 3Completed
- Sponsor
- Penta Foundation
- Start
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of dolutegravir, darunavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Penta Foundation. Primary endpoint: Confirmed virologic rebound through week 48. Started Sep 2015; status: completed.
02
Drugs
dolutegravirdarunavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN11193709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11193709.